U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C22H16N4O3
Molecular Weight 384.3874
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SB-431542

SMILES

NC(=O)C1=CC=C(C=C1)C2=NC(=C(N2)C3=CC=CC=N3)C4=CC5=C(OCO5)C=C4

InChI

InChIKey=FHYUGAJXYORMHI-UHFFFAOYSA-N
InChI=1S/C22H16N4O3/c23-21(27)13-4-6-14(7-5-13)22-25-19(20(26-22)16-3-1-2-10-24-16)15-8-9-17-18(11-15)29-12-28-17/h1-11H,12H2,(H2,23,27)(H,25,26)

HIDE SMILES / InChI

Molecular Formula C22H16N4O3
Molecular Weight 384.3874
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

SB-431542 was identified as a TGF-beta receptor type-1 inhibitor (IC50 = 94 nM) by scientists at GlaxoSmithKline. It has subsequently been studied in animal and cell models as a potential cancer treatment, although these efforts have been discontinued. Of note, SB-431542 was also used in a wound healing study where it was found to abolish the improved healing normally enhanced by treatment with Povidone-iodine.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: P36897
Gene ID: 7046.0
Gene Symbol: TGFBR1
Target Organism: Homo sapiens (Human)
94.0 nM [IC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Secondary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
TGF-beta1/Smad7 signaling stimulates renal tubulointerstitial fibrosis induced by AAI.
2008
Transforming growth factor beta2 regulates growth and differentiation of pulp cells via ALK5/Smad2/3.
2008 Apr
Transforming growth factor-beta1 regulates the fate of cultured spinal cord-derived neural progenitor cells.
2008 Apr
Transforming growth factor-beta stimulates intestinal epithelial focal adhesion kinase synthesis via Smad- and p38-dependent mechanisms.
2008 Aug
FK506 can activate transforming growth factor-beta signalling in vascular smooth muscle cells and promote proliferation.
2008 Aug 1
TGF-beta inhibits prolactin-induced expression of beta-casein by a Smad3-dependent mechanism.
2008 Aug 1
NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs.
2008 Aug 7
TGFbeta and SMADs talk to NANOG in human embryonic stem cells.
2008 Aug 7
Gamma-irradiation enhances RECK protein levels in Panc-1 pancreatic cancer cells.
2008 Feb 29
Improvement of the breaking strength of wound by combined treatment with recombinant human G-CSF, recombinant human M-CSF, and a TGF-beta1 receptor kinase inhibitor in rat skin.
2008 May
Expression of the type III TGF-beta receptor is negatively regulated by TGF-beta.
2008 May
Neurokinin-A inhibits cell cycle activators in K562 cells and activates Smad 4 through a non-canonical pathway: a novel method in neural-hematopoietic axis.
2008 Nov 15
Constitutive Smad signaling and Smad-dependent collagen gene expression in mouse embryonic fibroblasts lacking peroxisome proliferator-activated receptor-gamma.
2008 Sep 19
TGF-beta inhibits CYP17 transcription in H295R cells acting via activin receptor-like kinase 5.
2009
Graded Smad2/3 activation is converted directly into levels of target gene expression in embryonic stem cells.
2009
Overexpression of manganese superoxide dismutase in human dermal fibroblasts enhances the contraction of free floating collagen lattice: implications for ageing and hyperplastic scar formation.
2009 Apr
The core-aldehyde 9-oxononanoyl cholesterol increases the level of transforming growth factor beta1-specific receptors on promonocytic U937 cell membranes.
2009 Apr
SB-431542 inhibition of scar formation after filtration surgery and its potential mechanism.
2009 Apr
p38-Mitogen-activated protein kinase stimulated steroidogenesis in granulosa cell-oocyte cocultures: role of bone morphogenetic proteins 2 and 4.
2009 Apr
Dual functions for LTBP in lung development: LTBP-4 independently modulates elastogenesis and TGF-beta activity.
2009 Apr
Synthesis and biological evaluation of 1,2,4-trisubstituted imidazoles and 1,3,5-trisubstituted pyrazoles as inhibitors of transforming growth factor beta type 1 receptor (ALK5).
2009 Aug 15
Gap junction reduction in cardiomyocytes following transforming growth factor-beta treatment and Trypanosoma cruzi infection.
2009 Dec
Differential effects of TGFbeta and vitreous on the transformation of retinal pigment epithelial cells.
2009 Dec
Reduction of beta-amyloid-induced neurotoxicity on hippocampal cell cultures by moderate acidosis is mediated by transforming growth factor beta.
2009 Feb 18
TGF-beta-mediated activation of RhoA signalling is required for efficient (V12)HaRas and (V600E)BRAF transformation.
2009 Feb 19
TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch.
2009 Jan 21
Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis.
2009 Jul 15
Mesendodermal signals required for otic induction: Bmp-antagonists cooperate with Fgf and can facilitate formation of ectopic otic tissue.
2009 Jun
Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size.
2009 Jun
Disruption of bidirectional oocyte-cumulus paracrine signaling during in vitro maturation reduces subsequent mouse oocyte developmental competence.
2009 May
Tumour-derived prostaglandin E and transforming growth factor-beta synergize to inhibit plasmacytoid dendritic cell-derived interferon-alpha.
2009 Nov
A chemical platform for improved induction of human iPSCs.
2009 Nov
Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells.
2009 Nov
Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors.
2009 Nov 6
A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog.
2009 Nov 6
Nodal signaling via an autocrine pathway promotes proliferation of mouse spermatogonial stem/progenitor cells through Smad2/3 and Oct-4 activation.
2009 Oct
Activin/Nodal inhibition alone accelerates highly efficient neural conversion from human embryonic stem cells and imposes a caudal positional identity.
2009 Oct 6
Diabetes-relevant regulation of cultured blood outgrowth endothelial cells.
2009 Sep
Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
2009 Sep
Extra-ovarian expression and activity of growth differentiation factor 9.
2009 Sep
Desmoid cell motility is induced in vitro by rhEGF.
2009 Sep
In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction.
2009 Sep 1
VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression.
2009 Sep 15
Biphasic effects of selective inhibition of transforming growth factor beta1 activin receptor-like kinase on LPS-induced lung injury.
2010 Feb
Fuzheng Huayu recipe and vitamin E reverse renal interstitial fibrosis through counteracting TGF-beta1-induced epithelial-to-mesenchymal transition.
2010 Feb 17
BMP-3 promotes mesenchymal stem cell proliferation through the TGF-beta/activin signaling pathway.
2010 Jun
Inhibition of transforming growth factor-beta signalling attenuates interleukin (IL)-18 plus IL-2-induced interstitial lung disease in mice.
2010 Jun
MicroRNA-224 is involved in transforming growth factor-beta-mediated mouse granulosa cell proliferation and granulosa cell function by targeting Smad4.
2010 Mar
Interleukin 11 and activin A synergise to regulate progesterone-induced but not cAMP-induced decidualization.
2010 Mar
Transcriptional regulation of the small GTPase RhoB gene by TGF{beta}-induced signaling pathways.
2010 Mar
Patents

Sample Use Guides

100 random samples were collected from breast cancer patients who had undergone surgical resection. Mice were injected with cell suspensions containing MDA-MB-231-shCon \ MDA-MB-231-shNodal \ MCF-7-Nodal \ MCF- 7-Con. Three days after inoculation mice were dosed with 10 mg/kg of SB-431542 via intraperitoneal injection for four weeks on alternating days. After 4 weeks treatment with SB-431542 demonstrated tumor growth rate inhibition and weekend tumorigenicity.
Route of Administration: Intraperitoneal
Renal epithelial carcinoma A498 cells were serum starved for 24 h and then treated with various concentrations of SB-431542 for 48 hours to determine cellular toxicity. Cells survived with up tp 10 uM of SB-4831542 for 48 hours, indicating an LD50 > 30 uM. Furthermore, at a concentration of 1 uM SB-242235 was able to prevent the TGF-B–induced nuclear accumulation of Smad proteins. A dose response curve using 0, 50, 250, 500, and 700 nM SB-431542 was established and an IC50 of 50 nM was reported for inhibition of TGF-B1–induced nuclear fluorescence.
Substance Class Chemical
Created
by admin
on Sat Dec 16 08:19:53 GMT 2023
Edited
by admin
on Sat Dec 16 08:19:53 GMT 2023
Record UNII
E1557V1V0N
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SB-431542
Common Name English
4-(4-(1,3-BENZODIOXOLE-5-YL)-5-(2-PYRIDYL)-1H-IMIDAZOLE-2-YL)BENZAMIDE
Systematic Name English
BENZAMIDE, 4-(4-(1,3-BENZODIOXOL-5-YL)-5-(2-PYRIDINYL)-1H-IMIDAZOL-2-YL)-
Systematic Name English
J1.722.247C
Code English
Code System Code Type Description
FDA UNII
E1557V1V0N
Created by admin on Sat Dec 16 08:19:53 GMT 2023 , Edited by admin on Sat Dec 16 08:19:53 GMT 2023
PRIMARY
EPA CompTox
DTXSID7042693
Created by admin on Sat Dec 16 08:19:53 GMT 2023 , Edited by admin on Sat Dec 16 08:19:53 GMT 2023
PRIMARY
PUBCHEM
4521392
Created by admin on Sat Dec 16 08:19:53 GMT 2023 , Edited by admin on Sat Dec 16 08:19:53 GMT 2023
PRIMARY
CHEBI
91108
Created by admin on Sat Dec 16 08:19:53 GMT 2023 , Edited by admin on Sat Dec 16 08:19:53 GMT 2023
PRIMARY
CAS
301836-41-9
Created by admin on Sat Dec 16 08:19:53 GMT 2023 , Edited by admin on Sat Dec 16 08:19:53 GMT 2023
PRIMARY
WIKIPEDIA
SB-431542
Created by admin on Sat Dec 16 08:19:53 GMT 2023 , Edited by admin on Sat Dec 16 08:19:53 GMT 2023
PRIMARY